170 1997 Session Laws of Kansas Ch. 57
Be it enacted by the Legislature of the State of
Kansas:
Section 1. K.S.A. 65-2837a is hereby amended to read as follows:
65-
2837a. (a) It shall be unlawful for any person licensed to practice
medicine
and surgery to prescribe, order, dispense, administer, sell, supply
or give
any amphetamine or sympathomimetic amine designated in schedule
II,
III or IV under the uniform controlled substances act, except as
provided
in this section. Failure to comply with this section shall
constitute unpro-
fessional conduct under K.S.A. 65-2837 and amendments
thereto.
(b) When any licensee prescribes, orders, dispenses,
administers,
sells, supplies or gives any amphetamine or sympathomimetic amine
des-
ignated in schedule II, III or IV under the uniform controlled
substances
act, the patient's medical record shall adequately document and the
pre-
scription order shall indicate in the licensee's own handwriting,
the pur-
Ch. 57 1997 Session Laws of Kansas 171
pose for which the drug is being given. Such purpose shall be
restricted
to one or more of the following:
(1) The treatment of narcolepsy.
(2) The treatment of drug-induced brain dysfunction.
(3) The treatment of hyperkinesis.
(4) The differential diagnostic psychiatric evaluation of
depression.
(5) The treatment of depression shown by adequate medical
records
and documentation to be unresponsive to other forms of
treatment.
(6) The clinical investigation of the effects of such drugs or
com-
pounds, in which case, before the investigation is begun, the
licensee
shall, in addition to other requirements of applicable laws, apply
for and
obtain approval of the investigation from the board of healing
arts.
(7) The short-term treatment of obesity with
schedule III and IV controlled
substances, as may
amphetamines or sympathomimetic amines
be defined by rules and regulations adopted by the board of healing
arts.
(8) The treatment of any other disorder or disease for which
such
drugs or compounds have been found to be safe and effective by
com-
petent scientific research which findings have been generally
accepted by
the scientific community, in which case, before prescribing,
ordering,
dispensing, administering, selling, supplying or giving the drug or
com-
pound for a particular condition, the licensee shall obtain a
determination
from the board of healing arts that the drug or compound can be
used
for that particular condition.
Sec. 2. K.S.A. 65-2837a is hereby repealed.
Sec. 3. This act shall take effect and be in force from and
after its
publication in the statute book.
Approved April 4, 1997.